On November 13, 2024, Cardinal Health, Inc. (CAH, Financial) entered into an underwriting agreement with BofA Securities, Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC. This agreement facilitates the sale of a substantial $2.9 billion in aggregate principal amount through a series of notes with varying maturities and interest rates.
The offering includes $500 million of 4.700% Notes due in 2026, $750 million of 5.000% Notes due in 2029, $1 billion of 5.350% Notes due in 2034, and $650 million of 5.750% Notes due in 2054. This strategic move is part of Cardinal Health's broader financial strategy to optimize its capital structure and support its long-term growth objectives.
The notes were offered under Cardinal Health's effective registration statement on Form S-3, previously filed with the Securities and Exchange Commission. This significant financial maneuver underscores the company's commitment to maintaining a robust financial position while continuing to deliver value to its shareholders.
For more detailed information on the underwriting agreement and the specifics of the notes offering, interested parties can refer to the full text of the agreement filed with the SEC.
Should you invest in Cardinal Health Inc (CAH, Financial) right now? Before you do it, it’s important to understand the business profitability and stock valuations, and find out what the warning signs are about. See the in-depth Cardinal Health Inc (CAH) stock research here.
